News Headline Summary

FDA advisory panel vote 18 to 0 for J&J drug

- Data supports the efficacy of J&J drug Bedaquiline against resistant TB.

Reaction details (20:57)

- No immediate reaction to the news, last trade at USD 69.25 (+0.65%).

28 Nov 2012 - 20:55 - Equities Data - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: